Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy

• Status: Completed
• Trial end date: 2020-12-23
• Target enrollment: 0
• Participant gender: All

Summary

Patients with type 2 DM who are following will be enrolled into the study. Two visits were scheduled for data collection, physical examination and laboratory testing of the patients: the first prior to initiation of alpha lipoic acid (ALA) administration (baseline visit) and the second at the end of the third month following initiation of ALA (2nd visit).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University
• Treatments: Thioctic Acid

Criteria

Inclusion Criteria:

• Patient's agreement to participate

• Diabetic peripheral neuropathy

Exclusion Criteria:

• Causes of neuropathy other than diabetes

• Severe renal disease

• Recent treatment for cancer or haematological malignancies;

• Presence of foot ulcers;

• Peripheral arterial disease ;

• Use of agents in the previous 3 months that could interfere with the interpretation of results, such as opiates, vitamin B compounds or antioxidants;

• Pregnancy

• Lactation